Carboxymethylcellulose Calcium Market
完整報告名稱與涵蓋範圍
Carboxymethylcellulose Calcium Market by Form (Fine Powder, Standard Powder), Grade (Pharmaceutical Grade, Food Grade), End-use Industry, and Region - Global forecast to 2036
報告摘要
The carboxymethylcellulose calcium market is estimated to be valued at USD 0.06 billion in 2026 and reach USD 0.09 billion by 2036, at a CAGR of 4.8%. The demand for fine powder is high due to its extensive use in pharmaceutical tablet formulations, where carboxymethylcellulose calcium functions as an effective binder, diluent, and disintegrant. Its fine particle size supports uniform blending and distribution within formulations, while its ability to swell several times its original volume upon contact with water enables rapid tablet disintegration. In addition, fine powder grades are commercially available with established pharmacopeial specifications, supporting their widespread adoption by pharmaceutical manufacturers.
‘‘Pharmaceutical grade accounted for the largest share of the carboxymethylcellulose calcium market, in terms of value.’’
Pharmaceutical grade accounted for the largest share of the carboxymethylcellulose calcium market due to its extensive use as a tablet and capsule disintegrant, binder, and diluent in oral solid dosage formulations. Its ability to rapidly absorb water and swell several times its original volume promotes tablet breakup and supports effective drug release, making it valuable in a wide range of pharmaceutical formulations. In addition, pharmaceutical-grade products must meet stringent pharmacopeial quality and purity requirements, such as USP/NF, EP, and IP specifications, supporting their adoption by pharmaceutical manufacturers. The continued production of tablets and capsules, including generic and immediate-release formulations, therefore sustains demand for pharmaceutical-grade carboxymethylcellulose calcium.
‘‘In terms of value, medical devices & wound care accounted for the third-largest share of the overall carboxymethylcellulose calcium market.’’
Medical devices & wound care accounted for the third-largest share of the carboxymethylcellulose calcium market, primarily due to the material’s high water-absorption capacity, self-gelling behavior, tissue adhesion, and hemostatic properties. These characteristics make it suitable for the development of hemostatic agents, wound dressings, and other bleeding-control materials, where rapid fluid absorption and formation of a protective gel barrier are important. The presence of calcium ions can further support coagulation, while the material’s bioabsorbability and biocompatibility enhance its suitability for wound-management applications. Growing demand for advanced wound-care and bleeding-control solutions is therefore supporting the use of carboxymethylcellulose calcium in medical applications.
“Asia Pacific region accounted for the largest share in the carboxymethylcellulose calcium market, in terms of value.”
Asia Pacific accounted for the largest share of the carboxymethylcellulose calcium market due to its large and expanding pharmaceutical manufacturing base, particularly in China and India. The region has a strong presence of generic drug manufacturers and pharmaceutical formulation companies, supporting demand for carboxymethylcellulose calcium as an excipient in solid and liquid dosage formulations. Increasing healthcare expenditure, growing pharmaceutical production, and expansion of manufacturing capacities across emerging Asian economies are further supporting market growth. In addition, the presence of established chemical manufacturers and cost-competitive production capabilities enables a reliable regional supply of carboxymethylcellulose calcium. Growing demand for pharmaceutical and personal care formulations, supported by a large population and improving healthcare infrastructure, is also contributing to consumption. These factors have enabled Asia Pacific to maintain its leading position in the carboxymethylcellulose calcium market.
This study has been validated through primary interviews with industry experts globally. The primary sources have been divided into the following three categories:
• By Company Type: Tier 1 - 60%, Tier 2 - 20%, and Tier 3 - 20%
• By Designation: C-level - 33%, Director-level - 33%, and Managers - 34%
• By Region: North America - 20%, Europe - 25%, Asia Pacific - 30%, the Middle East & Africa - 15%, and South America - 10%
The report provides a comprehensive analysis of the following companies:
Prominent companies in this market include Anmol Chemicals Private Limited (India), Spectrum Chemicals (US), BOLAK Co., Ltd. (South Korea), Maple Biotech Pvt Ltd (India), Patel Chem Specialties Limited (India), Amit Hydrocolloids (India), Hiranya Cellulose Products (India), Jiangxi Alpha Hi-tech Pharmaceutical Co., Ltd. (China), Prachin Pharmachem (India), Maruti Chemicals (India), Amishi Drugs & Chemicals (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), and Gotoku Chemical Co., Ltd. (Japan).
Research coverage
This research report categorizes the carboxymethylcellulose calcium market By form (Fine Powder, Standard Powder), Grade (Pharmaceutical Grade, Food Grade, Other Grades), End-use Industry (Pharmaceutical Excipients, Medical Devices & Wound Care, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care, Other End-use Industries), Region (North America, Europe, Asia Pacific, the Middle East & Africa, and South America). The scope of the report includes detailed information about the major factors influencing the growth of the carboxymethylcellulose calcium market, such as drivers, restraints, challenges, and opportunities. A thorough examination of the key industry players has been conducted in order to provide insights into their business overview, solutions, and services, key strategies, contracts, partnerships, and agreements. New product and service launches, mergers and acquisitions, and recent developments in the carboxymethylcellulose calcium market are all covered. This report includes a competitive analysis of upcoming startups in the carboxymethylcellulose calcium market ecosystem.
Reasons to buy this report
The report will help market leaders/new entrants in this market with information on the closest approximations of revenue for the overall carboxymethylcellulose calcium market and its subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
• Analysis of key drivers (growing demand for oral solid dosage formulations, increasing need for rapid and consistent tablet disintegration), restraints (narrow application base than mainstream cellulose excipients, sensitivity to physical properties), opportunities (development of application-specific grades, expansion into multifunctional tablet formulations), and challenges (strong competition from alternative super disintegrants; increasing GMP, pharmacopeial, traceability, and documentation requirements) influencing the growth of the carboxymethylcellulose calcium market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and service launches in the carboxymethylcellulose calcium market
• Market Development: Comprehensive information about lucrative markets – the report analyses the carboxymethylcellulose calcium market across varied regions
• Market Diversification: Exhaustive information about services, untapped geographies, recent developments, and investments in the carboxymethylcellulose calcium market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players Anmol Chemicals Private Limited (India), Spectrum Chemicals (US), BOLAK Co., Ltd. (South Korea), Maple Biotech Pvt Ltd (India), Patel Chem Specialties Limited (India), Amit Hydrocolloids (India), Hiranya Cellulose Products (India), Jiangxi Alpha Hi-tech Pharmaceutical Co., Ltd. (China), Prachin Pharmachem (India), Maruti Chemicals (India), Amishi Drugs & Chemicals (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), and Gotoku Chemical Co., Ltd. (Japan), in the carboxymethylcellulose calcium market
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 STUDY SCOPE 23
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 23
1.3.2 INCLUSIONS AND EXCLUSIONS 24
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 25
1.3.5 UNITS CONSIDERED 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 25
2 EXECUTIVE SUMMARY 26
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 26
2.2 DISRUPTIVE TRENDS SHAPING MARKET 27
2.3 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 28
2.4 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 29
3 PREMIUM INSIGHTS 30
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CARBOXYMETHYLCELLULOSE
CALCIUM MARKET 30
3.2 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY AND REGION 31
3.3 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY FORM 32
3.4 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE 32
3.5 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY 33
4 MARKET OVERVIEW 34
4.1 INTRODUCTION 34
4.2 MARKET DYNAMICS 35
4.2.1 DRIVERS 35
4.2.1.1 Growing demand for oral solid dosage formulations 35
4.2.1.2 Increasing need for rapid and consistent tablet disintegration 35
4.2.1.3 Expansion of pharmaceutical manufacturing in emerging markets 36
4.2.1.4 Increasing adoption of pharmacopeial-grade Carmellose Calcium 36
4.2.2 RESTRAINTS 36
4.2.2.1 Narrow application base than mainstream cellulose excipients 36
4.2.2.2 Sensitivity to physical properties 36
4.2.2.3 Cost associated with maintaining pharmacopeial compliance 37
4.2.3 OPPORTUNITIES 37
4.2.3.1 Development of application-specific grades 37
4.2.3.2 Expansion into multifunctional tablet formulations 37
4.2.3.3 Expansion of regional manufacturing capacity 37
4.2.4 CHALLENGES 38
4.2.4.1 Strong competition from alternative superdisintegrants 38
4.2.4.2 Increasing GMP, pharmacopeial, traceability, and documentation requirements 38
4.2.4.3 Long customer qualification and formulation validation cycles 38
4.3 UNMET NEEDS AND WHITE SPACES 38
4.3.1 UNMET NEEDS IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 39
4.3.2 WHITE SPACE OPPORTUNITIES 40
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 41
4.4.1 INTERCONNECTED MARKETS 41
4.4.2 CROSS-SECTOR OPPORTUNITIES 42
4.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS 43
4.5.1 EMERGING BUSINESS MODELS 43
4.6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 43
4.6.1 KEY MOVES AND STRATEGIC FOCUS 44
5 INDUSTRY TRENDS 45
5.1 PORTER’S FIVE FORCES ANALYSIS 45
5.1.1 THREAT OF NEW ENTRANTS 46
5.1.2 THREAT OF SUBSTITUTES 46
5.1.3 BARGAINING POWER OF SUPPLIERS 47
5.1.4 BARGAINING POWER OF BUYERS 47
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 47
5.2 MACROECONOMICS INDICATORS 48
5.2.1 INTRODUCTION 48
5.2.2 GDP TRENDS AND FORECAST 48
5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL MANUFACTURING 50
5.3 SUPPLY CHAIN ANALYSIS 52
5.4 ECOSYSTEM ANALYSIS 53
5.5 PRICING ANALYSIS 55
5.5.1 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY END-USE INDUSTRY 56
5.5.2 AVERAGE SELLING PRICE TREND OF CARBOXYMETHYLCELLULOSE
CALCIUM, BY REGION 56
5.6 TRADE ANALYSIS, 2021–2025 58
5.6.1 IMPORT SCENARIO (HS CODE 391231) 58
5.6.2 EXPORT SCENARIO (HS CODE 391231) 59
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 61
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61
5.9 INVESTMENT AND FUNDING SCENARIO 62
5.10 CASE STUDY ANALYSIS 63
5.10.1 RIZATRIPTAN BENZOATE MOUTH-DISINTEGRATING TABLETS USING CARBOXYMETHYLCELLULOSE CALCIUM 63
5.10.2 DAICEL–NICHIRIN ORALLY DISINTEGRATING TABLET DEVELOPMENT 64
5.10.3 WUXI KAILI PHARMACEUTICAL – CARBOXYMETHYLCELLULOSE CALCIUM MANUFACTURING PROCESS DEVELOPMENT 64
5.11 IMPACT OF 2025 US TARIFF ON CARBOXYMETHYLCELLULOSE CALCIUM MARKET 65
5.11.1 INTRODUCTION 65
5.11.2 KEY TARIFF RATES 65
5.11.3 PRICE IMPACT ANALYSIS 66
5.11.4 IMPACT ON COUNTRIES/REGIONS 67
5.11.4.1 North America 67
5.11.4.2 Europe 67
5.11.4.3 Asia Pacific 67
5.11.5 IMPACT ON TOP END-USE INDUSTRIES 67
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 69
6.1 KEY EMERGING TECHNOLOGIES 69
6.1.1 CONTROLLED PARTICLE SIZE AND SWELLING ENGINEERED CARBOXYMETHYLCELLULOSE CALCIUM 69
6.1.2 CO-PROCESSED AND MULTI-DISINTEGRANT FORMULATION TECHNOLOG 70
6.2 COMPLEMENTARY TECHNOLOGIES 70
6.2.1 CONTINUOUS AND HIGH-SPEED TABLETING TECHNOLOGIES 70
6.3 TECHNOLOGY/PRODUCT ROADMAP 71
6.3.1 SHORT-TERM (2026–2028) | PERFORMANCE OPTIMIZATION & FORMULATION PENETRATION 71
6.3.2 MID-TERM (2028–2031) | EXPANSION & STANDARDIZATION 73
6.3.3 LONG-TERM (2032–2036+) | FUNCTIONAL EXCIPIENT ENGINEERING & HIGH-VALUE ADOPTION 75
6.4 PATENT ANALYSIS 77
6.4.1 INTRODUCTION 77
6.4.2 METHODOLOGY 77
6.4.3 DOCUMENT TYPES 77
6.4.4 INSIGHTS 79
6.4.5 LEGAL STATUS 79
6.4.6 JURISDICTION ANALYSIS 79
6.4.7 TOP APPLICANTS 80
6.4.8 TOP 10 PATENT OWNERS (US) IN LAST 5 YEARS 82
6.5 FUTURE APPLICATIONS 83
6.5.1 RAPID DISINTEGRATION ORAL TABLETS 83
6.5.2 ORALLY DISINTEGRATING TABLETS (ODTS) 84
6.5.3 DIRECT COMPRESSION TABLET FORMULATIONS 84
6.5.4 GENERIC & HIGH-VOLUME ORAL SOLID DOSAGE 85
6.5.5 HIGH-FUNCTIONALITY EXCIPIENT GRADES 85
6.6 IMPACT OF AI/GEN AI ON CARBOXYMETHYLCELLULOSE CALCIUM MARKET 86
6.6.1 TOP USE CASES AND MARKET POTENTIAL 86
6.6.2 BEST PRACTICES IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 87
6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 88
6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 90
7.1 REGIONAL REGULATIONS AND COMPLIANCE 90
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
7.2 SUSTAINABILITY INITIATIVES 93
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF CARBOXYMETHYLCELLULOSE CALCIUM 93
7.2.1.1 Carbon impact reduction 93
7.2.1.2 Eco-Applications 94
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 95
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 96
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 98
8.1 DECISION-MAKING PROCESS 98
8.2 STAKEHOLDERS AND BUYING EVALUATION CRITERIA 100
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
8.2.2 BUYING CRITERIA 101
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 101
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 102
8.5 MARKET PROFITABILITY 103
8.5.1 REVENUE POTENTIAL 103
8.5.2 COST DYNAMICS 104
8.5.3 MARGIN OPPORTUNITIES BY APPLICATION 104
9 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY FORM 105
9.1 INTRODUCTION 106
9.2 FINE POWDER 107
9.2.1 HIGHER SWELLING EFFICIENCY AND RAPID TABLET DISINTEGRATION TO SUPPORT DEMAND 107
9.3 STANDARD POWDER 107
9.3.1 BALANCED POWDER FLOW AND PROCESSING FLEXIBILITY TO SUSTAIN DEMAND 107
10 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE 108
10.1 INTRODUCTION 109
10.2 PHARMACEUTICAL GRADE 110
10.2.1 PHARMACOPOEIAL COMPLIANCE AND DISINTEGRANT PERFORMANCE TO SUPPORT MARKET LEADERSHIP 110
10.3 FOOD GRADE 111
10.3.1 EXPANDING USE IN POWDERED FOODS AND TEXTURE MODIFICATION TO SUPPORT DEMAND 111
10.4 OTHER GRADES 112
10.4.1 APPLICATION SPECIFIC GRADES TO SUPPORT INDUSTRIAL AND SPECIALTY DEMAND 112
11 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY 114
11.1 INTRODUCTION 115
11.2 PHARMACEUTICAL EXCIPIENTS 116
11.2.1 ESTABLISHED USE AS A DISINTEGRANT IN ORAL SOLID DOSAGE FORMULATIONS TO DRIVE DEMAND 116
11.3 COSMETICS & PERSONAL CARE 118
11.3.1 EMULSION STABILIZATION AND VISCOSITY CONTROL TO SUPPORT SPECIALTY FORMULATION DEMAND 118
11.4 NUTRACEUTICALS & DIETARY SUPPLEMENTS 119
11.4.1 EXPANDING TABLET AND CAPSULE FORMATS TO SUPPORT DEMAND 119
11.5 MEDICAL DEVICES & WOUND CARE 120
11.5.1 EMERGING USE IN HEMOSTATIC AND ADVANCED WOUND-CARE MATERIALS 120
11.6 OTHER END-USE INDUSTRIES 121
12 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION 123
12.1 INTRODUCTION 124
12.2 ASIA PACIFIC 125
12.2.1 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE 126
12.2.2 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY 127
12.2.3 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY 128
12.3 EUROPE 134
12.3.1 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE 135
12.3.2 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY 136
12.3.3 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY 137
12.4 NORTH AMERICA 144
12.4.1 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY GRADE 145
12.4.2 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY 145
12.4.3 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY COUNTRY 146
12.5 MIDDLE EAST & AFRICA 150
12.5.1 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE 151
12.5.2 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY 152
12.5.3 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY 153
12.5.4 GCC COUNTRIES 153
12.6 SOUTH AMERICA 160
12.6.1 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY GRADE 160
12.6.2 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY 161
12.6.3 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY COUNTRY 161
13 COMPETITIVE LANDSCAPE 165
13.1 OVERVIEW 165
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 165
13.3 MARKET SHARE ANALYSIS 167
13.4 BRAND COMPARISON 169
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 170
13.5.1 STARS 170
13.5.2 EMERGING LEADERS 170
13.5.3 PERVASIVE PLAYERS 170
13.5.4 PARTICIPANTS 171
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 172
13.5.5.1 Company footprint 172
13.5.5.2 Region footprint 173
13.5.5.3 Form footprint 174
13.5.5.4 Grade footprint 175
13.5.5.5 End-use industry footprint 176
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 177
13.6.1 PROGRESSIVE COMPANIES 177
13.6.2 RESPONSIVE COMPANIES 177
13.6.3 DYNAMIC COMPANIES 177
13.6.4 STARTING BLOCKS 177
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 179
13.6.5.1 Competitive benchmarking of key startups/SMEs 179
13.7 COMPETITIVE SCENARIO 180
13.7.1 OTHER DEVELOPMENTS 180
14 COMPANY PROFILES 181
14.1 KEY COMPANIES 181
14.1.1 ANMOL CHEMICALS PRIVATE LIMITED 181
14.1.1.1 Business overview 181
14.1.1.2 Products offered 182
14.1.1.3 MnM view 182
14.1.1.3.1 Right to win 182
14.1.1.3.2 Strategic choices 182
14.1.1.3.3 Weaknesses and competitive threats 183
14.1.2 SPECTRUM CHEMICAL 184
14.1.2.1 Business overview 184
14.1.2.2 Products offered 184
14.1.2.3 MnM view 185
14.1.2.3.1 Right to win 185
14.1.2.3.2 Strategic choices 185
14.1.2.3.3 Weaknesses and competitive threats 185
14.1.3 BOLAK CO., LTD. 186
14.1.3.1 Business overview 186
14.1.3.2 Products offered 187
14.1.3.3 MnM view 188
14.1.3.3.1 Right to win 188
14.1.3.3.2 Strategic choices 188
14.1.3.3.3 Weaknesses and competitive threats 188
14.1.4 MAPLE BIOTECH PVT. LTD. 189
14.1.4.1 Business overview 189
14.1.4.2 Products offered 189
14.1.4.3 MnM view 190
14.1.4.3.1 Right to win 190
14.1.4.3.2 Strategic choices 190
14.1.4.3.3 Weaknesses and competitive threats 190
14.1.5 SHREEJI PHARMA INTERNATIONAL 191
14.1.5.1 Business overview 191
14.1.5.2 Products offered 191
14.1.5.3 MnM view 192
14.1.5.3.1 Right to win 192
14.1.5.3.2 Strategic choices 192
14.1.5.3.3 Weaknesses and competitive threats 192
14.1.6 PATEL CHEM SPECIALITIES LIMITED 193
14.1.6.1 Business overview 193
14.1.6.2 Products offered 194
14.1.6.3 MnM view 195
14.1.6.3.1 Right to win 195
14.1.6.3.2 Strategic choices 195
14.1.6.3.3 Weaknesses and competitive threats 195
14.1.7 AMIT HYDROCOLLOIDS 196
14.1.7.1 Business overview 196
14.1.7.2 Products offered 196
14.1.7.3 MnM view 197
14.1.7.3.1 Right to win 197
14.1.7.3.2 Strategic choices 197
14.1.7.3.3 Weaknesses and competitive threats 197
14.1.8 HIRANYA CELLULOSE PRODUCTS 198
14.1.8.1 Business overview 198
14.1.8.2 Products offered 198
14.1.8.3 MnM view 199
14.1.8.3.1 Right to win 199
14.1.8.3.2 Strategic choices 199
14.1.8.3.3 Weaknesses and competitive threats 199
14.1.9 JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO., LTD. 200
14.1.9.1 Business overview 200
14.1.9.2 Products offered 201
14.1.9.3 MnM view 201
14.1.9.3.1 Right to win 201
14.1.9.3.2 Strategic choices 201
14.1.9.3.3 Weaknesses and competitive threats 202
14.1.10 PRACHIN PHARMACHEM 203
14.1.10.1 Business overview 203
14.1.10.2 Products offered 204
14.1.10.3 MnM view 204
14.1.10.3.1 Right to win 204
14.1.10.3.2 Strategic choices 204
14.1.10.3.3 Weaknesses and competitive threats 204
14.1.11 MARUTI CHEMICALS 205
14.1.11.1 Business overview 205
14.1.11.2 Products offered 205
14.1.11.3 MnM view 206
14.1.11.3.1 Key strengths 206
14.1.11.3.2 Strategic choices 206
14.1.11.3.3 Weaknesses & competitive threats 206
14.1.12 AMISHI DRUGS & CHEMICALS 207
14.1.12.1 Business overview 207
14.1.12.2 Products offered 207
14.1.12.3 Recent developments 208
14.1.12.3.1 Other developments 208
14.1.12.4 MnM view 208
14.1.12.4.1 Key strengths 208
14.1.12.4.2 Strategic choices 208
14.1.12.4.3 Weaknesses & competitive threats 208
14.1.13 ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO., LTD. 209
14.1.13.1 Business overview 209
14.1.13.2 Products offered 209
14.1.13.3 MnM view 210
14.1.13.3.1 Key strengths 210
14.1.13.3.2 Strategic choices 210
14.1.13.3.3 Weaknesses & competitive threats 210
14.1.14 GOTOKU CHEMICAL CO., LTD. 211
14.1.14.1 Business overview 211
14.1.14.2 Products offered 211
14.1.14.3 MnM view 212
14.1.14.3.1 Key strengths 212
14.1.14.3.2 Strategic choices 212
14.1.14.3.3 Weaknesses & competitive threats 212
14.1.15 YICHUN WONSEN INTELLIGENT EQUIPMENT CO., LTD. 213
14.1.15.1 Business overview 213
14.1.15.2 Products offered 213
14.1.15.3 MnM view 214
14.1.15.3.1 Key strengths 214
14.1.15.3.2 Strategic choices 214
14.1.15.3.3 Weaknesses & competitive threats 214
14.2 OTHER PLAYERS 215
14.2.1 SHANDONG YULONG CELLULOSE TECHNOLOGY CO., LTD. 215
14.2.2 GIHI CHEMICALS CO., LTD. 215
14.2.3 MUBY CHEMICALS 216
14.2.4 HANGZHOU LEAP CHEM CO., LTD. 216
14.2.5 DEV INTERNATIONAL 217
14.2.6 LABH INGREDIENTS 218
14.2.7 AADHUNIK INDUSTRIES 219
14.2.8 CELLULOSE PHARMA CHEM 219
14.2.9 PADMASHREE GROUP 220
14.2.10 LSV CHEMICAL (2022) CO., LTD. 220
15 RESEARCH METHODOLOGY 221
15.1 RESEARCH DATA 221
15.1.1 SECONDARY DATA 222
15.1.1.1 Key data from secondary sources 222
15.1.2 PRIMARY DATA 222
15.1.2.1 Key data from primary sources 223
15.1.2.2 Key primary interview participants 223
15.1.2.3 Breakdown of interviews with experts 224
15.1.2.4 Key industry insights 224
15.2 MARKET SIZE ESTIMATION 225
15.2.1 BOTTOM-UP APPROACH 225
15.2.2 TOP-DOWN APPROACH 225
15.3 BASE NUMBER CALCULATION 226
15.3.1 APPROACH 1: DEMAND-SIDE ANALYSIS 226
15.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS 227
15.4 FORECAST NUMBER CALCULATION 227
15.5 DATA TRIANGULATION 228
15.6 FACTOR ANALYSIS 230
15.7 RESEARCH ASSUMPTIONS 230
15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT 231
16 APPENDIX 232
16.1 DISCUSSION GUIDE 232
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
16.3 CUSTOMIZATION OPTIONS 237
16.4 RELATED REPORTS 237
16.5 AUTHOR DETAILS 238
圖表清單 List of Tables & Figures
TABLE 1 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: PORTER’S
FIVE FORCES ANALYSIS 46
TABLE 2 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2022–2030 48
TABLE 3 GLOBAL PHARMACEUTICAL MANUFACTURING: KEY INDICATORS SUPPORTING CMC-CA DEMAND 51
TABLE 4 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: ROLE IN ECOSYSTEM 54
TABLE 5 AVERAGE SELLING PRICE OF CARBOXYMETHYLCELLULOSE CALCIUM OFFERED
BY KEY PLAYERS, BY END-USE INDUSTRY, 2025 (USD/KG) 56
TABLE 6 AVERAGE SELLING PRICE TREND OF CARBOXYMETHYLCELLULOSE CALCIUM,
BY REGION, 2024–2025 (USD/KG) 57
TABLE 7 IMPORT DATA FOR HS CODE 391231 -COMPLIANT PRODUCTS,
2021–2025 (USD THOUSAND) 59
TABLE 8 EXPORT DATA FOR HS CODE 391231 -COMPLIANT PRODUCTS,
2021–2025 (USD THOUSAND) 60
TABLE 9 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 61
TABLE 10 TOP COUNTRY WITH RESPECTIVE TARIFF RATES 65
TABLE 11 EXPECTED CHANGE IN PRICES AND IMPACT ON END-USE MARKET DUE TO TARIFFS 66
TABLE 12 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: TOTAL NUMBER OF PATENTS 78
TABLE 13 LIST OF PATENTS BY CHUGAI PHARMACEUTICAL CO., LTD. 81
TABLE 14 LIST OF PATENTS BY ALBIREO AB 81
TABLE 15 LIST OF PATENTS BY TAKEDA PHARMACEUTICAL COMPANY 82
TABLE 16 TOP USE CASES AND MARKET POTENTIAL 86
TABLE 17 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 87
TABLE 18 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 88
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 23 CERTIFICATIONS, LABELING, ECO-STANDARDS IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 96
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY (%) 100
TABLE 25 KEY BUYING CRITERIA, BY END-USE INDUSTRY 101
TABLE 26 UNMET NEEDS IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET
BY END-USE INDUSTRY 103
TABLE 27 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY FORM,
2024–2036 (USD MILLION) 106
TABLE 28 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY FORM, 2024–2036 (TON) 107
TABLE 29 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE,
2024–2036 (USD MILLION) 110
TABLE 30 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 (TON) 110
TABLE 31 PHARMACEUTICAL GRADE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (USD MILLION) 111
TABLE 32 PHARMACEUTICAL GRADE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (TON) 111
TABLE 33 FOOD GRADE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (USD MILLION) 112
TABLE 34 FOOD GRADE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (TON) 112
TABLE 35 OTHER GRADES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (USD MILLION) 113
TABLE 36 OTHER GRADES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY REGION, 2024–2036 (TON) 113
TABLE 37 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY,
2024–2036 (USD MILLION) 116
TABLE 38 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY,
2024–2036 (TON) 116
TABLE 39 PHARMACOPOEIAL/PRODUCT STANDARDS IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 117
TABLE 40 PHARMACEUTICAL EXCIPIENTS: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (USD MILLION) 118
TABLE 41 PHARMACEUTICAL EXCIPIENTS: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 118
TABLE 42 COSMETICS & PERSONAL CARE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (USD MILLION) 119
TABLE 43 COSMETICS & PERSONAL CARE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 119
TABLE 44 NUTRACEUTICALS & DIETARY SUPPLEMENTS: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (USD MILLION) 120
TABLE 45 NUTRACEUTICALS & DIETARY SUPPLEMENTS: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 120
TABLE 46 MEDICAL DEVICES & WOUND CARE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (USD MILLION) 121
TABLE 47 MEDICAL DEVICES & WOUND CARE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 121
TABLE 48 OTHER END-USE INDUSTRIES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (USD MILLION) 122
TABLE 49 OTHER END-USE INDUSTRIES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 122
TABLE 50 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION,
2024–2036 (USD MILLION) 125
TABLE 51 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY REGION, 2024–2036 (TON) 125
TABLE 52 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE,
2024–2036 (USD MILLION) 126
TABLE 53 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE,
2024–2036 (TON) 127
TABLE 54 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 127
TABLE 55 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 127
TABLE 56 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (USD MILLION) 128
TABLE 57 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (TON) 128
TABLE 58 CHINA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 129
TABLE 59 CHINA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 129
TABLE 60 INDIA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 130
TABLE 61 INDIA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 131
TABLE 62 JAPAN: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 132
TABLE 63 JAPAN: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 132
TABLE 64 SOUTH KOREA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 133
TABLE 65 SOUTH KOREA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 133
TABLE 66 REST OF ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 134
TABLE 67 REST OF ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (TON) 134
TABLE 68 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE,
2024–2036 (USD MILLION) 135
TABLE 69 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE,
2024–2036 (TON) 136
TABLE 70 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 136
TABLE 71 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 136
TABLE 72 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY,
2024–2036 (USD MILLION) 137
TABLE 73 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY,
2024–2036 (TON) 137
TABLE 74 GERMANY: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 138
TABLE 75 GERMANY: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 138
TABLE 76 FRANCE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 139
TABLE 77 FRANCE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 139
TABLE 78 UK: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 140
TABLE 79 UK: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 140
TABLE 80 ITALY: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 141
TABLE 81 ITALY: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 141
TABLE 82 SPAIN: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 142
TABLE 83 SPAIN: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 142
TABLE 84 REST OF EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 143
TABLE 85 REST OF EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 143
TABLE 86 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 (USD MILLION) 145
TABLE 87 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 (TON) 145
TABLE 88 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 145
TABLE 89 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 146
TABLE 90 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (USD MILLION) 146
TABLE 91 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (TON) 146
TABLE 92 US: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 147
TABLE 93 US: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 148
TABLE 94 CANADA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 149
TABLE 95 CANADA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 149
TABLE 96 MEXICO: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 150
TABLE 97 MEXICO: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 150
TABLE 98 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY GRADE, 2024–2036 (USD MILLION) 151
TABLE 99 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY GRADE, 2024–2036 (TON) 151
TABLE 100 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 152
TABLE 101 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (TON) 152
TABLE 102 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY COUNTRY, 2024–2036 (USD MILLION) 153
TABLE 103 MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY COUNTRY, 2024–2036 (TON) 153
TABLE 104 SAUDI ARABIA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 154
TABLE 105 SAUDI ARABIA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 155
TABLE 106 UAE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 156
TABLE 107 UAE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 156
TABLE 108 REST OF GCC COUNTRIES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 157
TABLE 109 REST OF GCC COUNTRIES: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (TON) 157
TABLE 110 SOUTH AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 158
TABLE 111 SOUTH AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 158
TABLE 112 REST OF MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 159
TABLE 113 REST OF MIDDLE EAST & AFRICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 159
TABLE 114 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 (USD MILLION) 160
TABLE 115 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 (TON) 160
TABLE 116 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 161
TABLE 117 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 161
TABLE 118 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (USD MILLION) 161
TABLE 119 SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY COUNTRY, 2024–2036 (TON) 162
TABLE 120 BRAZIL: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 162
TABLE 121 BRAZIL: CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY, 2024–2036 (TON) 163
TABLE 122 REST OF SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (USD MILLION) 163
TABLE 123 REST OF SOUTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET,
BY END-USE INDUSTRY, 2024–2036 (TON) 164
TABLE 124 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: KEY STRATEGIES ADOPTED
BY MAJOR PLAYERS 165
TABLE 125 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: DEGREE OF COMPETITION, 2025 167
TABLE 126 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: REGION FOOTPRINT 173
TABLE 127 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: FORM FOOTPRINT 174
TABLE 128 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: GRADE FOOTPRINT 175
TABLE 129 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: END-USE INDUSTRY FOOTPRINT 176
TABLE 130 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (1/2) 179
TABLE 131 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (2/2) 179
TABLE 132 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: OTHER DEVELOPMENTS, JANUARY 2022 – AUGUST 2026 180
TABLE 133 ANMOL CHEMICALS PRIVATE LIMITED: COMPANY OVERVIEW 181
TABLE 134 ANMOL CHEMICALS PRIVATE LIMITED: PRODUCTS OFFERED 182
TABLE 135 SPECTRUM CHEMICAL: COMPANY OVERVIEW 184
TABLE 136 SPECTRUM CHEMICAL: PRODUCTS OFFERED 184
TABLE 137 BOLAK CO., LTD.: COMPANY OVERVIEW 186
TABLE 138 BOLAK CO., LTD.: PRODUCTS OFFERED 187
TABLE 139 MAPLE BIOTECH PVT. LTD.: COMPANY OVERVIEW 189
TABLE 140 MAPLE BIOTECH PVT. LTD.: PRODUCTS OFFERED 189
TABLE 141 SHREEJI PHARMA INTERNATIONAL: COMPANY OVERVIEW 191
TABLE 142 SHREEJI PHARMA INTERNATIONAL: PRODUCTS OFFERED 191
TABLE 143 PATEL CHEM SPECIALITIES LIMITED: COMPANY OVERVIEW 193
TABLE 144 PATEL CHEM SPECIALITIES LIMITED: PRODUCTS OFFERED 194
TABLE 145 AMIT HYDROCOLLOIDS: COMPANY OVERVIEW 196
TABLE 146 AMIT HYDROCOLLOIDS: PRODUCTS OFFERED 196
TABLE 147 HIRANYA CELLULOSE PRODUCTS: COMPANY OVERVIEW 198
TABLE 148 HIRANYA CELLULOSE: PRODUCTS OFFERED 198
TABLE 149 JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 200
TABLE 150 JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED 201
TABLE 151 PRACHIN PHARMACHEM: COMPANY OVERVIEW 203
TABLE 152 PRACHIN PHARMACHEM: PRODUCTS OFFERED 204
TABLE 153 MARUTI CHEMICALS: COMPANY OVERVIEW 205
TABLE 154 MARUTI CHEMICALS: PRODUCTS OFFERED 205
TABLE 155 AMISHI DRUGS & CHEMICALS: COMPANY OVERVIEW 207
TABLE 156 AMISHI DRUGS & CHEMICALS: PRODUCTS OFFERED 207
TABLE 157 AMISHI DRUGS & CHEMICALS: OTHER DEVELOPMENTS 208
TABLE 158 ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO., LTD.: COMPANY OVERVIEW 209
TABLE 159 ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO., LTD.: PRODUCTS OFFERED 209
TABLE 160 GOTOKU CHEMICAL CO., LTD.: COMPANY OVERVIEW 211
TABLE 161 GOTOKU CHEMICAL CO., LTD.: PRODUCTS OFFERED 211
TABLE 162 YICHUN WONSEN INTELLIGENT EQUIPMENT CO., LTD.: COMPANY OVERVIEW 213
TABLE 163 YICHUN WONSEN INTELLIGENT EQUIPMENT CO., LTD.: PRODUCTS OFFERED 213
TABLE 164 SHANDONG YULONG CELLULOSE TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 215
TABLE 165 GIHI CHEMICALS CO., LTD.: COMPANY OVERVIEW 215
TABLE 166 MUBY CHEMICALS: COMPANY OVERVIEW 216
TABLE 167 HANGZHOU LEAP CHEM CO., LTD.: COMPANY OVERVIEW 216
TABLE 168 DEV INTERNATIONAL: COMPANY OVERVIEW 217
TABLE 169 LABH INGREDIENTS: COMPANY OVERVIEW 218
TABLE 170 AADHUNIK INDUSTRIES: COMPANY OVERVIEW 219
TABLE 171 CELLULOSE PHARMA CHEM: COMPANY OVERVIEW 219
TABLE 172 PADMASHREE GROUP: COMPANY OVERVIEW 220
TABLE 173 LSV CHEMICAL (2022) CO., LTD.: COMPANY OVERVIEW 220
TABLE 174 LIST OF PRIMARY INTERVIEW PARTICIPANTS 223
FIGURE 1 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: SEGMENTATION AND
REGIONAL SCOPE 23
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 26
FIGURE 3 GLOBAL CARBOXYMETHYLCELLULOSE CALCIUM MARKET, 2025–2036 27
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF CARBOXYMETHYLCELLULOSE CALCIUM MARKET 27
FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN CARBOXYMETHYLCELLULOSE CALCIUM MARKET 28
FIGURE 6 ASIA PACIFIC IS THE FASTEST GROWING REGION IN THE GLOBAL CARBOXYMETHYLCELLULOSE CALCIUM MARKET 29
FIGURE 7 HIGH DEMAND IN PHARMACEUTICAL EXCIPIENTS INDUSTRY TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 30
FIGURE 8 PHARMACEUTICAL EXCIPIENTS SEGMENT AND ASIA PACIFIC ACCOUNTED FOR LARGEST MARKET SHARE OF CARBOXYMETHYLCELLULOSE CALCIUM IN 2025 31
FIGURE 9 FINE POWDER CARBOXYMETHYLCELLULOSE CALCIUM SEGMENT TO REGISTER HIGHEST GROWTH DURING PROJECTED PERIOD 32
FIGURE 10 PHARMACEUTICAL GRADE CARBOXYMETHYLCELLULOSE CALCIUM SEGMENT TO REGISTER HIGHEST CAGR DURING PROJECTED PERIOD 32
FIGURE 11 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 33
FIGURE 12 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 13 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: PORTER’S FIVE FORCES ANALYSIS 45
FIGURE 14 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: SUPPLY CHAIN ANALYSIS 52
FIGURE 15 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: KEY STAKEHOLDERS IN ECOSYSTEM 53
FIGURE 16 AVERAGE SELLING PRICE TREND OF CARBOXYMETHYLCELLULOSE CALCIUM,
BY REGION, 2024–2025 (USD/KG) 57
FIGURE 17 IMPORT SCENARIO FOR HS CODE 391231 -COMPLIANT PRODUCTS,
BY KEY COUNTRIES, 2021–2025 58
FIGURE 18 EXPORT SCENARIO FOR HS CODE 391231-COMPLIANT PRODUCTS,
BY KEY COUNTRIES, 2021–2025 59
FIGURE 19 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 62
FIGURE 20 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: INVESTMENT AND FUNDING SCENARIO, 2025 63
FIGURE 21 PATENT ANALYSIS, BY DOCUMENT TYPE 78
FIGURE 22 PATENT PUBLICATION TREND, 2016−2026 78
FIGURE 23 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: LEGAL STATUS OF PATENTS 79
FIGURE 24 US DOMINATES IN PATENT ACTIVITY BETWEEN 2016 AND 2026 80
FIGURE 25 TORAY INDUSTRIES, INC. REGISTERED HIGHEST NUMBER OF PATENTS 80
FIGURE 26 FUTURE APPLICATIONS 83
FIGURE 27 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: DECISION-MAKING FACTORS 99
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY 100
FIGURE 29 KEY BUYING CRITERIA, BY END-USE INDUSTRY 101
FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES 102
FIGURE 31 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY FORM, 2026–2036 106
FIGURE 32 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY GRADE, 2024–2036 109
FIGURE 33 CARBOXYMETHYLCELLULOSE CALCIUM MARKET, BY END-USE INDUSTRY,
2024–2036 115
FIGURE 34 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 124
FIGURE 35 ASIA PACIFIC: CARBOXYMETHYLCELLULOSE CALCIUM MARKET SNAPSHOT 126
FIGURE 36 EUROPE: CARBOXYMETHYLCELLULOSE CALCIUM MARKET SNAPSHOT 135
FIGURE 37 NORTH AMERICA: CARBOXYMETHYLCELLULOSE CALCIUM MARKET SNAPSHOT 144
FIGURE 38 CARBOXYMETHYLCELLULOSE CALCIUM MARKET SHARE ANALYSIS, 2025 167
FIGURE 39 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: BRAND COMPARISON 169
FIGURE 40 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 171
FIGURE 41 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: COMPANY FOOTPRINT 172
FIGURE 42 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2025 178
FIGURE 43 BOLAK CO., LTD.: COMPANY SNAPSHOT 187
FIGURE 44 PATEL CHEM SPECIALITIES LIMITED: COMPANY SNAPSHOT 194
FIGURE 45 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: RESEARCH DESIGN 221
FIGURE 46 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH & TOP-DOWN APPROACH 225
FIGURE 47 CARBOXYMETHYLCELLULOSE CALCIUM MARKET: DATA TRIANGULATION 229
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們